Immediate Impact

69 standout
Sub-graph 1 of 23

Citing Papers

Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons
2025 Standout
A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus
2025 Standout
4 intermediate papers

Works of Laura Ferlic‐Stark being referenced

Clinical characteristics and outcomes of respiratory syncytial virus infection in pregnant women
2019
Comparison of Palivizumab-Like Antibody Binding to Different Conformations of the RSV F Protein in RSV-Infected Adult Hematopoietic Cell Transplant Recipients
2018
and 1 more

Author Peers

Author Last Decade Papers Cites
Laura Ferlic‐Stark 132 172 57 129 15 309
Bhavna Mahadeb 121 199 24 180 22 365
Florence Aulagnon 85 99 22 63 9 364
João Luiz Miraglia 112 118 5 50 25 349
Danièle Vauthier‐Brouzes 35 111 24 80 13 360
Colin Anderson‐Smits 88 53 14 52 22 309
Christina Boros 66 31 27 55 14 292
David Chi Kong Luk 71 72 17 42 17 357
Aslı Karadeniz 63 76 24 71 25 257
Andreas Woerner 66 34 56 197 26 362
Y.A.S. Sens 90 66 52 13 15 363

All Works

Loading papers...

Rankless by CCL
2026